CD8A and neoplasm: On the other hand, increased expression of PD-L1 and PD-1 in tumor cells, of exhaustion markers (like TIM3 and FOXP3) on T cells, and the reduction of the frequency of CD8+ T cell infiltrate have been reported in histologic samples of patients progressing to BRAF inhibitors [61,62].